Video

Data

Text duration start ents sentiment
authorization for its covenant 19 4.16 Jump to 4.0
    CARDINAL 19
vaccine has 90 efficacy but those trials 4.8 Jump to 8.16
    CARDINAL 90
now in a first on cnbc interview is 3.841 Jump to 19.039
    ORDINAL first
two years ago in this process a year and 4.48 Jump to 47.2
    DATE two years ago
    DATE a year
basically zero capacity and we've built 3.84 Jump to 51.68
    CARDINAL zero
and then the first quarter will be a 3.519 Jump to 103.92
    DATE the first quarter
scale where we can produce over 2 7.28 Jump to 105.6
    CARDINAL 2
billion doses in 2022 on a global basis 5.441 Jump to 107.439
    DATE 2022
well a couple unique features uh one is 5.36 Jump to 145.04
did our phase three efficacy trials 5.44 Jump to 188.879
    CARDINAL three